Clinical Guides
Childhood Asthma
A source-grounded guide to recognising, confirming and managing asthma in children, aligned with current WHO, IAP, NHM and NMC guidance and has been reviewed by the MedNext Clinical Team.
MedNext Academy | 12 min read
Childhood Asthma
A source-grounded guide to recognising, confirming and managing asthma in children, aligned with current WHO, IAP, NHM and NMC guidance and has been reviewed by the MedNext Clinical Team.
Summary
Childhood asthma is a chronic inflammatory airway disorder characterised by variable respiratory symptoms and variable expiratory airflow limitation. Typical symptoms are wheeze, cough, breathlessness and chest tightness that vary over time and intensity, often worsening with viral infections, exercise, laughter, allergens, smoke or pollution. Not every noisy breath is asthma: bronchiolitis, pneumonia, foreign-body aspiration, upper-airway obstruction and congenital disease must be considered, particularly in infants or an atypical presentation.
Diagnosis combines a characteristic recurrent pattern with objective evidence when age and access permit. Spirometry demonstrating obstruction and bronchodilator reversibility supports asthma; peak-flow variability or response to a supervised controller trial may assist when spirometry is unavailable. Normal results between episodes do not automatically exclude disease. In preschool children, diagnosis is probability-based and requires repeated review.
Every child needs an inhaled corticosteroid-containing controller strategy appropriate to age and severity, correct device and spacer technique, adherence support, trigger reduction and a written action plan. Reliever-only treatment leaves airway inflammation untreated. Acute attacks require rapid severity assessment, oxygen for hypoxaemia, repeated inhaled bronchodilator and timely systemic corticosteroid according to a verified local protocol; silent chest, exhaustion or altered consciousness is life-threatening.
WHO issued consolidated global guidance in May 2026, while IAP published Indian rational allergy-practice guidance in 2026 and NHM F-IMNCI provides Indian first-referral assessment pathways. Availability and age approvals differ, so this quarantined guide avoids brand-specific regimens and remains reviewed pending paediatric review.
How Common Is It?
Asthma is among the commonest chronic diseases of childhood and a major cause of recurrent symptoms, missed school, emergency visits and preventable hospitalisation. Burden varies between countries and within India because diagnostic practice, air quality, urbanisation, tobacco exposure, housing, access to spirometry and treatment all differ. Symptom surveys and clinician-diagnosed prevalence measure different things, so figures cannot be transferred uncritically between settings.
Many children first wheeze during viral infections, but only some develop persistent asthma. Preschool phenotypes change over time; early labels such as episodic viral wheeze can help description but do not perfectly predict school-age disease. Atopy, recurrent interval symptoms and a strong family history increase probability, yet absence of allergy does not exclude asthma. Some children improve around puberty, while others relapse or continue into adulthood.
Severe outcomes disproportionately affect children with poor access to inhaled corticosteroids, incorrect technique, inconsistent use, tobacco or biomass exposure, psychosocial barriers and previous severe attacks. A child whose day-to-day symptoms seem mild may still experience a dangerous exacerbation. Recent emergency attendance, intensive care, excessive reliever use and failure to collect controller medicine are stronger warning signals than a casual label of mild asthma.
This guide does not assert a single current national Indian childhood prevalence. WHO 2026 supplies global normative guidance, not India-specific epidemiology. Services should use local surveillance when available and separate diagnosed prevalence from symptom prevalence. The clinically actionable count is each child's symptom frequency, night waking, activity limitation, reliever use and attacks over time.
Risk Factors
Asthma arises from interaction between genetic susceptibility and environmental exposure. Atopic dermatitis, allergic rhinitis, allergen sensitisation and parental asthma increase probability, but no single factor is diagnostic. Viral respiratory infections commonly precipitate attacks. Tobacco smoke, vaping aerosols, biomass smoke, traffic pollution, occupational exposures brought home on clothing, damp and mould may worsen control. Avoid blaming families when structural housing or outdoor pollution cannot be individually controlled.
Exercise, laughter, cold air and strong emotions can trigger bronchoconstriction but healthy activity should not be prohibited; symptoms with activity usually signal inadequate control or preparation. Food rarely causes isolated chronic asthma, although anaphylaxis can include bronchospasm. Routine restrictive diets are inappropriate without a confirmed allergy. Obesity, rhinitis, reflux symptoms, sleep-disordered breathing and anxiety can complicate assessment and control.
Risk of severe attack is increased by previous ventilation or intensive care, hospitalisation in the past year, recent systemic corticosteroids, excessive short-acting bronchodilator reliance, absent or poorly used inhaled corticosteroid, incorrect technique, poor perception of airflow limitation and psychosocial or access barriers. A history of rapid-onset attacks demands a particularly explicit emergency plan.
Medication and system risks matter. Empty inhalers, unaffordable refills, devices a young child cannot coordinate, absent spacer, language mismatch and fragmented school care produce apparent treatment failure. Before escalating therapy, check diagnosis, technique, adherence, exposure and comorbidity. Escalation without these checks increases adverse effects while leaving the root cause unchanged.
Diagnosis
Asthma is diagnosed from recurrent variable symptoms plus evidence of variable expiratory airflow limitation where feasible. Reassess over time because one visit may occur between episodes.
History
Characterise wheeze, cough, breathlessness and tightness: onset, duration, frequency, night waking, exercise limitation, seasonal pattern and interval wellness. Ask about viral, allergen, smoke, pollution and medicine triggers; emergency visits, steroids, admission or ventilation; inhaler use, spacer technique and adherence. Explore eczema, rhinitis, food allergy, family history, prematurity, choking onset, feeding symptoms, growth and tuberculosis contact. Clarify whether the sound was clinician-confirmed wheeze rather than stridor or nasal noise.
Examination
Record respiratory rate, work of breathing, oxygen saturation, ability to speak or feed, heart rate and mental state during symptoms. Listen for polyphonic expiratory wheeze and air entry; a silent chest is dangerous. Between episodes examination may be normal. Assess growth, clubbing, asymmetry, stridor, cardiac signs, eczema, rhinitis and obesity. Observe inhaler-spacer technique directly and check device dose counter or remaining supply.
Investigations
In children generally able to perform it, spirometry before and after bronchodilator is preferred; interpret against age-appropriate reference values. Peak expiratory-flow variability or exercise/bronchial challenge may support specialist evaluation. FeNO and allergy testing identify treatable traits but do not independently diagnose asthma. Chest radiograph, CBC, CT and infection testing are not routine; order them for atypical features or alternatives. In preschool children, document probability, response to a supervised controller trial and planned diagnostic review.
Differential Diagnosis
In infants, bronchiolitis causes an acute viral syndrome with crackles or wheeze and should not automatically become an asthma diagnosis. Recurrent viral wheeze may evolve, while persistent symptoms from birth suggest airway malacia, congenital heart disease, bronchopulmonary dysplasia or cystic fibrosis. Poor growth, clubbing, chronic wet cough or recurrent focal pneumonia is atypical and warrants broader investigation.
Sudden onset during eating or play, unilateral wheeze or asymmetric air entry suggests inhaled foreign body even if choking was unwitnessed. Stridor, voice change or inspiratory noise points to upper-airway disease. Vocal cord dysfunction or inducible laryngeal obstruction can mimic exertional asthma, especially when symptoms are inspiratory and resolve rapidly. Habit cough and dysfunctional breathing require positive diagnosis, not dismissal.
In India, pulmonary tuberculosis enters the differential with chronic cough, weight loss, fever, exposure or suggestive imaging; it does not usually cause classic variable wheeze alone. Pneumonia produces fever, focal signs or hypoxaemia. Parasitic or eosinophilic lung disease, allergic bronchopulmonary aspergillosis and primary ciliary dyskinesia are less common but relevant in selected presentations.
Gastro-oesophageal reflux may coexist but empiric acid suppression is not asthma treatment without relevant symptoms. Cardiac failure, pulmonary hypertension and anaemia can cause breathlessness. A poor response should trigger checks of technique and adherence, then reconsideration of diagnosis. Repeated antibiotic or cough-syrup courses without documenting variability, airflow or alternative disease delay effective care.
Management
Agree goals with child and caregiver: no troublesome day or night symptoms, full activity, minimal attacks and minimal treatment burden. Explain chronic airway inflammation and demonstrate the chosen inhaler with an age-appropriate spacer. Ask the child or caregiver to teach back. Provide a written action plan stating daily controller, response to worsening symptoms and when to seek emergency care. Review technique and adherence at every visit.
Use an inhaled corticosteroid-containing strategy for all confirmed asthma, selected by age, symptom pattern, risk and local availability. Step up only after checking diagnosis, technique, adherence, exposures and comorbidity; step down cautiously after sustained control with follow-up. Treat rhinitis, support vaccination and healthy activity, and reduce tobacco and biomass exposure. Allergen avoidance should be targeted to a clinically relevant sensitisation, not impose broad expensive changes.
For an acute attack, assess severity immediately. Give inhaled short-acting bronchodilator through pressurised metered-dose inhaler and spacer where effective and feasible; oxygen targets, repeated dosing, ipratropium, systemic corticosteroid and intravenous therapy follow age- and severity-specific emergency protocols. Reassess response using symptoms, work of breathing, air entry, saturation and objective flow when possible. Antibiotics are not routine.
After every attack, identify why it happened, restore controller therapy, check device supply and arrange early review. School staff need access to reliever and an action plan. Specialist biologics are reserved for carefully phenotyped severe asthma after fundamentals are optimised, with India-specific licensing and affordability checked.
Prescribing Information
This guide intentionally avoids individual doses. Select an inhaled corticosteroid or combination through a current paediatric formulary because dose categories, device delivery and age licences differ. Confirm medicine, device, spacer compatibility, inspiratory ability and technique. Rinse mouth after corticosteroid, use the lowest effective dose and monitor growth trajectory, oral candidiasis, dysphonia and cumulative systemic-steroid exposure. Poor technique can mimic drug failure.
Short-acting beta2 agonist relieves bronchoconstriction but does not treat inflammation. Frequent need, early canister replacement or reliance without controller is a risk signal requiring urgent review. Tremor and tachycardia can occur. Long-acting beta2 agonist should not be used without inhaled corticosteroid in asthma. Maintenance-and-reliever strategies depend on age, product and guideline eligibility; never assume all formoterol combinations are interchangeable.
Systemic corticosteroids are used for defined moderate or severe attacks, not recurrent unsupervised home courses. Verify weight, product concentration, maximum duration, comorbidity and recent exposure. Repeated courses increase metabolic, behavioural, infection, bone and adrenal risks. Ipratropium and intravenous bronchodilators belong to acute-care severity protocols with monitoring.
Check interactions and contraindications, and identify aspirin or NSAID sensitivity where relevant. Avoid sedating cough suppressants, mucolytics, routine antibiotics and unproven herbal substitutes. Prescriptions should include generic medicine, strength, device, spacer, technique check, action-plan role and review date. Ensure families can actually obtain the same device taught.
When to Refer
Refer urgently or admit when oxygen saturation is low, work of breathing is severe, the child cannot speak, feed or walk normally, air entry is poor, response to initial bronchodilator is inadequate, or exhaustion, cyanosis, confusion or silent chest appears. Previous life-threatening asthma lowers the threshold. Transfer must include continued acute treatment and monitoring, not a passive referral note.
Seek paediatric respiratory or allergy review when diagnosis is uncertain, symptoms began unusually early, examination or imaging is focal, growth is poor, wet cough persists, attacks remain frequent, or control is poor despite verified technique and adherence at an appropriate treatment step. Refer after intensive care, repeated admission, repeated systemic steroid, suspected occupational or complex allergy trigger, or consideration of biologic therapy.
Objective testing referral is useful when spirometry, bronchodilator reversibility, FeNO or challenge testing is unavailable locally and the result would change management. Allergy testing should answer a targeted question. ENT, sleep, obesity, mental-health or physiotherapy support may address comorbid rhinitis, sleep-disordered breathing, weight, anxiety or dysfunctional breathing.
Provide trends: symptoms, night waking, activity, reliever use, attacks, steroid courses, saturation, spirometry, technique, adherence, exposures and current medicines. Continue an appropriate controller while awaiting routine review. A specialist appointment is not a substitute for an emergency plan or reliable medicine supply.
Red Flags
Life-threatening signs are a silent or nearly silent chest, exhaustion, altered consciousness, cyanosis, inability to speak, severe hypoxaemia, bradycardia or poor respiratory effort. These require emergency resuscitation, oxygen and senior paediatric support. Wheeze becoming quieter while the child worsens indicates less airflow, not recovery. Peak flow should never delay treatment in a distressed child.
Marked recession, inability to feed, agitation, persistent low saturation, poor response to repeated inhaled bronchodilator or rapid deterioration also requires urgent transfer. Families should seek immediate care when the action-plan reliever gives little or short-lived benefit, speech is interrupted, the child is drowsy or lips turn blue. Children with a prior intensive-care attack need a lower threshold.
Diagnostic red flags include sudden choking onset, unilateral findings, stridor, chronic wet cough, clubbing, failure to thrive, symptoms from birth, recurrent focal pneumonia, haemoptysis, cardiac signs or persistent fever. These do not prove an alternative but make routine asthma escalation unsafe. Tuberculosis exposure with systemic features needs appropriate evaluation and infection-control consideration.
Risk can be high between attacks. Excessive reliever use, absent controller, repeated oral steroids, missed follow-up, unaffordable medicines, household smoke and poor symptom perception require active intervention. Ask about school access and device supply. A child who appears well today still needs urgent risk reduction after a recent severe exacerbation.
Indian Clinical Context
The IAP 2026 Rational Allergy Practice Guidelines provide current Indian professional guidance across childhood asthma and related allergic disease. NHM's revised F-IMNCI 2023 participant module supplies first-referral assessment and management charts, including asthma-related wheeze, for Indian child-health services. WHO 2026 is global normative guidance and should be labelled as an international framework rather than a national India protocol.
Access varies: some centres offer spirometry, FeNO and biologics, while many rely on repeated clinical review and therapeutic response. Lack of a test does not justify indefinite reliever-only treatment, but diagnostic uncertainty must be recorded. Pressurised metered-dose inhalers with spacers are portable and effective when technique and supply are assured; improvised spacers should follow validated local policy, not casual instruction.
Outdoor pollution, biomass cooking smoke, tobacco, seasonal dust, mould and cost affect control. Clinicians should offer feasible exposure reduction without implying families can control ambient air. Verify medicine availability through public services and avoid switching device brands without reteaching technique. School plans should be understandable to teachers and permit rapid reliever access.
This guide does not claim uniform Indian prevalence, universal spirometry or a single nationally stocked inhaler combination. Local protocols must reconcile WHO and IAP recommendations with age licensing, NHM pathways and formulary. Explain in the family's preferred language that inhaled corticosteroid is preventive and is not an addictive rescue medicine.
NMC Competency Mapping
The NMC CBME Curriculum 2024 maps childhood asthma directly within Paediatrics Topic 28. PE28.2 addresses pathogenesis and presentation, PE28.3 diagnosis, PE28.4 management of chronic asthma and PE28.5 management of acute severe asthma. Pharmacology PH5.1 supports selection and safe use of inhaled medicines. Teaching should preserve the exact competency wording and expected performance level.
Learners should elicit variable symptoms and triggers, distinguish wheeze from stridor, assess interval control and attack risk, and recognise alternative diagnoses. They should perform respiratory examination, measure saturation, interpret age-appropriate spirometry and bronchodilator response, and understand the limitations of preschool testing. A normal between-episode examination does not exclude asthma.
Supervised skills include grading an attack, administering inhaled bronchodilator with spacer, choosing an inhaled corticosteroid-containing strategy through an approved protocol, checking technique, writing an action plan and counselling about smoke exposure. Students must identify silent chest, exhaustion and altered consciousness as emergencies. Drug doses should be assessed using a provided verified reference rather than memory alone.
Integration spans physiology, pathology, pharmacology, allergy, emergency medicine, community health and communication. Case assessment should test both day-to-day control and future risk. NMC mapping does not make this draft clinically approved; named reviewer sign-off remains necessary before publication.
Key Exam Pearls for NEET PG
Asthma combines variable symptoms with variable expiratory airflow limitation. Common clues are recurrent wheeze, night or early-morning cough, exercise symptoms and trigger-related variability. Spirometry with bronchodilator reversibility supports diagnosis in a cooperative child. Preschool diagnosis remains probability-based and must be reviewed. Normal examination or spirometry between attacks does not automatically exclude asthma.
Always distinguish bronchiolitis in an infant, foreign body with sudden or unilateral findings, upper-airway stridor, chronic suppurative lung disease with wet cough or clubbing, and cardiac disease. Chest radiography and CBC are not routine in typical asthma. FeNO supports type-2 inflammation but is not a standalone diagnostic test.
Controller treatment must contain inhaled corticosteroid; reliever-only care is unsafe. Before stepping up, check diagnosis, inhaler-spacer technique, adherence, exposures and comorbidities. LABA is not asthma monotherapy. Frequent SABA use, oral-steroid courses, hospitalisation and past intensive care predict risk. After an attack, restore controller care and arrange early review.
A silent chest, exhaustion, confusion, cyanosis or poor respiratory effort is life-threatening. Acute management prioritises oxygen for hypoxaemia, repeated inhaled bronchodilator and timely systemic steroid under protocol. For NMC, remember PE28.2 through PE28.5: pathogenesis/presentation, diagnosis, chronic management and acute severe asthma.
Frequently Asked Questions
Can a child have asthma when examination is normal?
Yes. Asthma varies, so examination and spirometry may be normal between episodes. Diagnosis uses the repeated symptom pattern and objective variability when feasible. Preschool children need probability-based assessment and review. Sudden, focal, wet-cough or growth-related features should trigger evaluation for another diagnosis.
Why is an inhaled corticosteroid needed if symptoms are occasional?
Airway inflammation can exist even when symptoms are infrequent, and severe attacks can occur in children described as mild. An age-appropriate inhaled corticosteroid-containing strategy reduces risk. The exact regimen depends on age, severity, product and local guidance, with technique and adherence checked.
Does using an inhaler mean the child is addicted?
No. Controller and reliever inhalers treat airway inflammation or bronchoconstriction; they do not cause addiction. Apparent dependence on frequent reliever often signals poor control, absent controller, incorrect technique or ongoing exposure and should prompt review rather than stopping treatment. A clinician should check the device, spacer, adherence and written plan and explain each inhaler's different role.
Which childhood asthma signs require immediate emergency medical care?
Seek emergency care for severe breathlessness, inability to speak or feed, marked chest recession, blue lips, drowsiness, exhaustion, poor response to the action-plan reliever or a silent chest. A quieter wheeze with worsening effort can mean critically reduced airflow, not improvement. Continue the written emergency plan during transfer, keep the child supervised and upright when possible, and do not delay care to measure peak flow or search for old prescriptions.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic